Trial intelligence / Profile preview

Immunogenicity of COVID-19 vaccines in KCMH health care workers

TCTR20210325003Unknown

Sponsor
Ratchadaphiseksomphot Endowment Fund
Start
Mar 2021
Countries
1
01

Overview

Trial in coronavirus disease 2019 (COVID-19), sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoint: Immunogenicity of COVID-19 vaccines. Status: unknown.

02

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on TCTR20210325003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210325003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call